Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Syringes are medical devices used to inject fluid or withdraw fluid from the body. A medical syringe consists of a needle attached to a hollow cylinder that is fitted with a sliding plunger. Smart syringe are designed with safety mechanisms, in order to prevent the needle stick injuries and reuse of syringes. The unsafe usage of syringe is observed by the World Health Organization globally, which leads to widespread infection amongst healthcare professionals and patients. Unsafe syringe usage can cause abscesses, septicaemia and nerve damage, in severe cases hemorrhagic fevers and malaria is also transmitted.

Moreover, according to the World Health Organization, 2014, around 2 million healthcare professionals suffered from infectious diseases, as a result of needlestick injuries, globally. The smart syringe aids to overcome this problem, thereby acting as an ideal device to reduce the occurrence of needlestick injuries.

The global smart syringe market is estimated to be valued at US$ 7,332.7 million in 2020 and is expected to exhibit a CAGR of 11.3% over the forecast period (2020-2027).

Figure 1. Global Smart Syringe Market Share (%) in Terms of Value, By Region, 2019

Smart Syringe  | Coherent Market Insights

Increasing prevalence of chronic diseases such as diabetes is expected to propel the market growth over the forecast period

Increasing incidence of diabetes across the world is one of the primary factor, which is expected to drive growth of the global smart syringe market as diabetic patients need to subcutaneously administer insulin regularly. For instance, according to the International Diabetes Federation, in 2019, around 463 million adults (20-79 years) were living with diabetes; by 2045 this will rise to 700 million worldwide. Moreover, 1 in 5 of the people who are above 65 years old have diabetes.

Furthermore, according to the National Diabetes Statistics Report 2017 published by Centers of Disease Control and Prevention (CDC), around 9.4% of the American population, which include all age groups i.e., pediatric, adults, and geriatric population accounting for 30.3 million people suffered from diabetes, whereas 33.9% of the rest of population was diagnosed with pre-diabetes.

request-sample

Smart Syringe Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 7,332.7 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 11.3% 2027 Value Projection: US$ 15,542.2 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Auto-disable Syringes, Active Safety Syringes, Passive Safety Syringes.
  • By Application: Vaccination, Drug Delivery, Blood Specimen Collection.
  • By End User: Hospitals & Clinics, Diagnostic Laboratories, Homecare Settings
Companies covered:

Becton, Dickinson and Company, Gerresheimer AG, Sharps Technology, Inc., Cardinal Health, lomMedical, MHC Medical Products, Sol-Millennium Medical Group, UltiMed Inc., Vogt Medical, Retractable Technologies, Inc., DMC Medical Limited, BIOCORP, Hindustan Syringes & Medical Devices Ltd, and Owen Mumford Ltd.

Growth Drivers:
  • Increasing prevalence of chronic diseases
  • Increasing technological advancements in smart syringes
Restraints & Challenges:
  • Availability of alternative drug delivery devices
  • Increasing number of people facing needle phobia

Increasing technological advancements in smart syringes by market players is expected to drive the market growth over the forecast period

Advancements in technology and improvements in designs, materials, construction, and fill volumes of syringes are expected to accelerate the market growth. For instance, on January 23, 2020, Gerresheimer AG, a Germany-based manufacturer of drug delivery devices, expanded its Gx RTF ClearJect product line by introducing the Gx RTF ClearJect polymer needle syringe, 2.25 ml. The syringe is made from cyclic olefin polymer (COP), a high performance polymer. The company displayed the new product at Pharmapack, the European hub for the pharma packaging and drug delivery device industry, in Paris on February 5 and 6, 2020.

Figure 2. Global Smart Syringe Market Share (%) in Terms of Value, By Product Type, 2019

Smart Syringe  | Coherent Market Insights

Global Smart Syringe Market – Impact of Coronavirus (Covid-19) Pandemic

Since the COVID-19 outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 93 million cases and 2 million deaths due to coronavirus disease (COVID-19) were reported up till January 17, 2021 across the globe.

Moreover, on December 14, 2020, the U.K. authorities reported a new variant SARS-CoV-2 VOC 202012/01, of COVID-19 to the World Health Organization due to which parts of U.K. entered the third COVID-19 lockdown. Similarly, on December 18, 2020, the national authorities in South Africa reported another new variant of COVID-19 501Y.V2:

Rapidly increasing cases of COVID-19 has encouraged the biopharmaceutical industry as well as the researchers around the world to develop the vaccine for the virus, as a result of which the demand of smart syringe has surged dynamically.

On 16 January 2020, the Indian government kicked off world’s largest vaccination drive to combat the COVID-19 pandemic. The Government of India collaborated with several market players in order to meet the demand of auto-disabled syringes for COVID vaccines. For instance, on December 29, 2020, Hindustan Syringes and Medical Devices (HMD), a manufacturer of medical disposables, announced that it has ramped up the production of Kojak Auto Disable (AD) syringes, in order to meet the demand for COVID vaccine. The company is planning to increase its production from 700 million Kojak Auto Disable (AD) syringes a year to over one billion by June 2021.

Smart Syringe Market Restraint

However, availability of alternative drug delivery devices that can replace smart syringe such as needle free injectors, and others and increasing number of people facing needle phobia are the factors that are expected to hinder the market growth.

For instance, according to a study published in January 2019 (in PubMed), needle phobia affects at least 20% to 50% adolescents and 20% to 30% adults globally.

Key Players

Major players operating in the global smart syringe market include Becton, Dickinson and Company, Gerresheimer AG, Sharps Technology, Inc., Cardinal Health, lomMedical, MHC Medical Products, Sol-Millennium Medical Group, UltiMed Inc., Vogt Medical, Retractable Technologies, Inc., DMC Medical Limited, BIOCORP, Hindustan Syringes & Medical Devices Ltd, and Owen Mumford Ltd.

Smart syringes can be classified in three categories, auto-disabled syringes (widely used for vaccination drives), Active Safety Syringes (the hypodermic protection is activated by the user), and Passive Safety Syringes (retract automatically after the use).

Smart syringes cater to various applications including drug delivery, vaccination, and blood specimen collection. Moreover, increasing demand for blood donations is also fuelling growth of the smart syringe market. For instance, according to the World Health Organization (WHO), 112.5 million blood donations were collected globally every year and there is an increase of 10.7 million blood donations from unpaid donors reported from 2008 to 2013. Furthermore, according to the American National Red Cross, around 7,000 units of platelets and 10,000 units of plasma are required daily in the U.S. and nearly 21 million blood components are transfused each year in the U.S.

Market Dynamics

Major factor driving growth of the smart syringe market include increasing launches of new products in the market and technological advancements in the smart syringes. For instance, on July 06, 2020, Sharps Technology, Inc., a provider of smart safety syringes, announced that the company has received approval from the U.S. Food and Drug Administration (FDA) for SHARPS PROVENSA smart safety syringes and is planning to commence the production in fourth quarter of 2020. SHARPS PROVENSA is designed with a propriety shield to cover the needle point making the syringe incapable of reuse and eliminating accidental needlestick injuries.

Similarly, on October 06, 2020, Gerresheimer AG, announced that the company will offer its Gx RTF syringes with a twist-off closure system, SG ITC (Integrated Tip Cap). The new system offers syringe closure with more stability providing extra protection to the drug product.

Key features of the study:

  • This report provides in-depth analysis of the global smart syringe market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global smart syringe market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Becton, Dickinson and Company, Gerresheimer AG, Sharps Technology, Inc., Cardinal Health, lomMedical, MHC Medical Products, Sol-Millennium Medical Group, UltiMed Inc., Vogt Medical, Retractable Technologies, Inc., DMC Medical Limited, BIOCORP, Hindustan Syringes & Medical Devices Ltd, and Owen Mumford Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global smart syringe market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smart syringe market

Detailed Segmentation:

  • Global Smart Syringe Market, By Product Type:
    • Auto-disable Syringes
    • Active Safety Syringes
    • Passive Safety Syringes 
  • Global Smart Syringe Market, By Application:
    • Vaccination
    • Drug Delivery
    • Blood Specimen Collection
  • Global Smart Syringe Market, By End User:
    • Hospitals & Clinics
    • Diagnostic Laboratories
    • Homecare Settings
  • Global Smart Syringe Market, By Region:
    • North America
      • By Product Type
        • Auto-disable Syringes
        • Active Safety Syringes
        • Passive Safety Syringes 
      • By Application
        • Vaccination
        • Drug Delivery
        • Blood Specimen Collection
      • By End User:
        • Hospitals & Clinics
        • Diagnostic Laboratories
        • Homecare Settings
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type
        • Auto-disable Syringes
        • Active Safety Syringes
        • Passive Safety Syringes
      • By Application
        • Vaccination
        • Drug Delivery
        • Blood Specimen Collection
      • By End User:
        • Hospitals & Clinics
        • Diagnostic Laboratories
        • Homecare Settings
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type
        • Auto-disable Syringes
        • Active Safety Syringes
        • Passive Safety Syringes
      • By Application
        • Vaccination
        • Drug Delivery
        • Blood Specimen Collection
      • By End User:
        • Hospitals & Clinics
        • Diagnostic Laboratories
        • Homecare Settings
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type
        • Auto-disable Syringes
        • Active Safety Syringes
        • Passive Safety Syringes
      • By Application
        • Vaccination
        • Drug Delivery
        • Blood Specimen Collection
      • By End User:
        • Hospitals & Clinics
        • Diagnostic Laboratories
        • Homecare Settings
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type
        • Auto-disable Syringes
        • Active Safety Syringes
        • Passive Safety Syringes
      • By Application
        • Vaccination
        • Drug Delivery
        • Blood Specimen Collection
      • By End User:
        • Hospitals & Clinics
        • Diagnostic Laboratories
        • Homecare Settings
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type
        • Auto-disable Syringes
        • Active Safety Syringes
        • Passive Safety Syringes
      • By Application
        • Vaccination
        • Drug Delivery
        • Blood Specimen Collection
      • By End User:
        • Hospitals & Clinics
        • Diagnostic Laboratories
        • Homecare Settings
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Becton, Dickinson and Company*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Gerresheimer AG
    • Sharps Technology, Inc.
    • Cardinal Health
    • lomMedical
    • MHC Medical Products
    • Sol-Millennium Medical Group
    • UltiMed Inc.
    • Vogt Medical
    • Retractable Technologies, Inc.
    • DMC Medical Limited
    • BIOCORP
    • Hindustan Syringes & Medical Devices Ltd
    • Owen Mumford Ltd

“*” marked represents similar segmentation in other categories in the respective section.       

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • PEST Analysis
  4. Global Smart Syringe Market – Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Epidemiology
    • Safety Syringes for COIVD-19 Vaccines
  5. Global Smart Syringe Market, By Product Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Auto-disable Syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Active Safety Syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Passive Safety Syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Smart Syringe Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Vaccination
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Drug Delivery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Blood Specimen Collection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Smart Syringe Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals & Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Homecare Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Global Smart Syringe Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Becton, Dickinson and Company
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Gerresheimer AG
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sharps Technology, Inc.
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cardinal Health
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • lomMedical
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • MHC Medical Products
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sol-Millennium Medical Group
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • UltiMed Inc.
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Vogt Medical
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Retractable Technologies, Inc.
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • DMC Medical Limited
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • BIOCORP
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hindustan Syringes & Medical Devices Ltd
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Owen Mumford Ltd
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 35 figures on "Smart Syringe Market” - Global forecast to 2027

FAQgrowicon

Frequently Asked Questions

The market size is estimated to surpass US$ 15,542.2 million by 2027.
The market is expected to exhibit a CAGR of 11.3% during the forecast period (2020-2027).
Increasing prevalence of chronic diseases and increasing technological advancements in smart syringes by market players are driving the market growth.
Auto-disable syringes segment is expected to hold major market share, owing to increasing awareness about vaccines and immunization among the populace.
North America market is expected to generate highest revenue share during the forecast period.
Major factors hampering growth of the market include factors such as availability of alternative drug delivery devices that can replace smart syringe such as needle free injectors, and others and increasing number of people facing needle phobia.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.